Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2007

Mar 7, 2007

33510_dirs_2007-03-07_e9873609-8045-45dc-a2d8-5a4600c70280.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISRY.OB)
CIK: 0000728387
Period of Report: 2007-03-02

Reporting Person: Hunt Jonathan Robert (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-03-02 stock option (right to buy) $4.4 A 15000 Acquired 2017-03-02 common stock (15000) Direct

Footnotes

F1: 5,000 stock options vest 03/02/2008, 5,000 stock options vest 03/02/2009, 5,000 stock options vest 03/02/2010